Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration
NCT00777374
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
97
Enrollment
OTHER
Sponsor class
Conditions
Allergic Rhinoconjunctivitis
Interventions
DRUG:
Patch
DRUG:
Placebo patch
Sponsor
University of Zurich